Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

NCT05537701 · tracked via the Priya Life Science Belgium tracker

Sponsor

Centre Hospitalier Universitaire de Liege

Phase

Observational

Started

2022-10-03

Last updated

2024-01-16

Condition(s) studied

Non-small Cell Lung Cancer

Study summary

The primary objective is to describe eosinophil infiltration in resected (early stage) NSCLC.

Secondary objectives are:

* to investigate the correlation of T-Eos and B-Eos in the aforementioned patient population;
* to investigate the correlation between T-Eos and overall \& disease-free survival;
* to investigate the localization of T-Eos (periphery vs. center of the tumor lesions).

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Resected, early stage NSCLC between 01-01-2015 and 30-04-2022 with available tumour tissue Exclusion Criteria: * Inclusion in a clinical study contraindicating enrollment in the present study

Primary outcome measure(s)

Percentage of tumor associated tissue eosinophilia by immunohistochemistry and computerised quantification — October 2022

Trial sites (1)

Facility	City	Region	Status
CHU de Liege	Liège	Belgium

More Centre Hospitalier Universitaire de Liege trials in Belgium

Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening Recruiting

Optimizing Care for Diabetic Patients in Hospitalized Rehabilitation Through Structured Education Starting soon

Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer Recruiting

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility. Recruiting

Natural History Study for Patients With Angelman Syndrome Recruiting

Other trials for the same condition

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC Recruiting

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) Active, not recruiting

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) Active, not recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05537701 on ClinicalTrials.gov ↗ ← All trials in Belgium